More on IKT

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+7.7% Growth)
- Ratings (7.5 Score)

Upcoming Events

- Earnings (11/16/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Inhibikase Therapeutics (NQ:IKT)
Delayed: 1.65 -0.18 (9.84%)
Prev. Close $1.83  
Open$1.82 
52 Wk High$ 
52 Wk Low$ 
Day High$1.82 
Day Low$1.65 
P/E N/A  
EPS$ 
Volume917,215 


Oct 13, 2026 02:59 AM Chardan Starts Inhibikase Therapeutics Inc (IKT) at Neutral
Oct 2, 2026 04:01 PM Inhibikase Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Aug 26, 2026 04:07 PM Form 8-K Inhibikase Therapeutics, For: Aug 21
Aug 14, 2026 05:23 PM Form SCHEDULE 13G/A Inhibikase Therapeutics, Filed by: PERCEPTIVE ADVISORS LLC
Aug 14, 2026 04:48 PM Form SCHEDULE 13G/A Inhibikase Therapeutics, Filed by: Nantahala Capital Management, LLC
Aug 13, 2026 11:49 AM Form SCHEDULE 13G/A Inhibikase Therapeutics, Filed by: Sands Capital Life Sciences Pulse Fund II, L.P.
Aug 11, 2026 05:05 PM Inhibikase Therapeutics (IKT) Reports In-Line Q2 EPS
Aug 11, 2026 04:28 PM Form S-8 Inhibikase Therapeutics,
Aug 11, 2026 04:18 PM Form 10-Q Inhibikase Therapeutics, For: Jun 30
Aug 11, 2026 04:09 PM Form 8-K Inhibikase Therapeutics, For: Aug 11
View All Articles

Entities mentioned with IKT

View All Entities